Does clinical pharmacy service improves quality use of medicines in patients with chronic non communicable diseases? Evidence from a controlled trial in sri lanka.

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Presentation
  • By: SHANIKA, Lelwala Guruge Thushani (University of Sri Jayewardenapura, Allied Health Science, Nugegoda, Sri Lanka)
  • Co-author(s): Lelwala Guruge Thushani Shanika: B.Pharm degree program, Department of Allied Health Science, Faculty of Medical Sciences, University of Sri Jayewardenapura, Nugegoda, Sri Lanka;, South Asian Clinical Toxicology Research Collaboration, Sri Lanka
    Nirmala Wijekoon: Department of Pharmacology, Faculty of Medical Sciences, University of Sri Jayewardenapura, Nugegoda, Sri Lanka
    Shaluka Jayamanne: Department of Medicine, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka;, South Asian Clinical Toxicology Research Collaboration, Sri Lanka
    Judith Coombes: South Asian Clinical Toxicology Research Collaboration, Sri Lanka
    Ian Coombes: South Asian Clinical Toxicology Research Collaboration, Sri Lanka
    Dhineli Perera: South Asian Clinical Toxicology Research Collaboration, Sri Lanka
    Cathy Lynch: South Asian Clinical Toxicology Research Collaboration, Sri Lanka
    Asita de Silva: Department of Pharmacology, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
    Andrew Dawson: South Asian Clinical Toxicology Research Collaboration, Sri Lanka
  • Abstract:

    Methods

    This was a non randomized controlled clinical trial conducted in a tertiary care hospital in Sri Lanka. The control group (CG) received standard care. The intervention group (IG) received CPS in addition to the standard care. The pharmacist performed a prospective medication review and made recommendations to the health care team when

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login